Allero Therapeutics is a startup.
Allero Therapeutics is a biotechnology company developing non-invasive, antigen-specific immunotherapies to induce long-lasting immune tolerance for autoimmune and allergic diseases and to prevent anti-drug antibodies. Its proprietary SOMIT (Specific OroMucosal ImmunoTherapy) platform is being applied to programs including celiac disease and food allergy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.